The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)

Organizer: Naoki Kishimoto (Grad. Sch. Pharm. Sci., kumamoto Univ), Hirokazu Tamamura (Lab. Biomat. Bioeng., Inst. Sci. Tokyo), Shogo Misumi (Grad. Sch. Pharm. Sci., Kumamoto Univ), Mikako Fujita (Grad. Sch. Pharm. Sci., Kumamoto Univ), Yasumasa Iwatani (NMC Nagoya Med. Ctr.)

The COVID-19 pandemic had reaffirmed that the research and development of antiviral drugs and vaccines during peacetime serve as a foundation for rapid response during a pandemic. Because viruses rely on their hosts and mimic host mechanisms, the key to success in drug and vaccine development is identifying therapeutic targets specific to the virus. By exploring and accumulating knowledge on the molecular targets for viruses, we can also strengthen preparedness for the emergence of future viral infectious diseases. Here, leading researchers in fields such as viral infectious disease internal medicine, pharmaceutical chemistry, drug discovery chemistry, and vaccinology are invited to give presentations relevant to this year's theme. This symposium started in 2014 and marks its 11th edition this year, the focus of which is on "Shaping Therapeutic Innovation Through Target Molecules." It is a joint symposium with the Division of Medicinal Chemistry, the Division of Organic Chemistry, and the Division of Chemical Pharmacy, and researchers involved in the development of general drugs and antimicrobial drugs are also invited. The aim is to foster multi-faceted discussions, leading to new insights and ideas for drug discovery.